News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
305,576 Results
Type
Article (43493)
Company Profile (103)
Press Release (261980)
Section
Business (82529)
Career Advice (508)
Deals (9098)
Drug Delivery (36)
Drug Development (52340)
Employer Resources (47)
FDA (6936)
Job Trends (6308)
News (147100)
Policy (10262)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (4)
2024 Bio NC Digital (5)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (2559)
Academic (1)
Accelerated approval (4)
Adcomms (17)
Allergies (32)
Alliances (21994)
ALS (61)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (111)
Approvals (6956)
Artificial intelligence (103)
Autoimmune disease (14)
Automation (8)
Bankruptcy (56)
Best Places to Work (5548)
BIOSECURE Act (7)
Biosimilars (38)
Biotechnology (89)
Bladder cancer (51)
Brain cancer (24)
Breast cancer (191)
Cancer (1756)
Cardiovascular disease (68)
Career advice (451)
Career pathing (10)
CAR-T (154)
Cell therapy (442)
Cervical cancer (16)
Clinical research (40847)
Collaboration (450)
Compensation (121)
Complete response letters (10)
COVID-19 (1715)
CRISPR (36)
C-suite (156)
Cystic fibrosis (69)
Data (1411)
Decentralized trials (1)
Denatured (12)
Depression (9)
Diabetes (101)
Diagnostics (2775)
Digital health (3)
Diversity (5)
Diversity, equity & inclusion (17)
Drug discovery (66)
Drug pricing (20)
Drug shortages (3)
Duchenne muscular dystrophy (52)
Earnings (20082)
Editorial (10)
Employer branding (4)
Employer resources (44)
Events (41065)
Executive appointments (484)
FDA (7530)
Featured Employer (18)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (372)
Gene editing (88)
Generative AI (6)
Gene therapy (246)
GLP-1 (252)
Government (1664)
Grass and pollen (1)
Guidances (18)
Healthcare (8523)
Huntington's disease (10)
IgA nephropathy (14)
Immunology and inflammation (69)
Indications (18)
Infectious disease (1785)
Inflammatory bowel disease (77)
Inflation Reduction Act (3)
Influenza (27)
Intellectual property (40)
Interviews (78)
IPO (4585)
IRA (9)
Job creations (1020)
Job search strategy (407)
Kidney cancer (10)
Labor market (6)
Layoffs (177)
Leadership (3)
Legal (1337)
Liver cancer (59)
Lung cancer (299)
Lymphoma (136)
Machine learning (2)
Management (13)
Manufacturing (128)
MASH (33)
Medical device (3789)
Medtech (3792)
Mergers & acquisitions (4730)
Metabolic disorders (232)
Multiple sclerosis (57)
NASH (8)
Neurodegenerative disease (50)
Neuropsychiatric disorders (3)
Neuroscience (1086)
NextGen: Class of 2025 (2665)
Non-profit (2146)
Northern California (1305)
Now hiring (7)
Obesity (96)
Opinion (80)
Ovarian cancer (66)
Pain (23)
Pancreatic cancer (50)
Parkinson's disease (67)
Partnered (9)
Patents (88)
Patient recruitment (66)
Peanut (20)
People (36309)
Pharmaceutical (13)
Phase I (14423)
Phase II (18447)
Phase III (12320)
Pipeline (599)
Podcasts (39)
Policy (35)
Postmarket research (1420)
Preclinical (6932)
Press Release (59)
Prostate cancer (69)
Psychedelics (16)
Radiopharmaceuticals (146)
Rare diseases (256)
Real estate (2145)
Recruiting (21)
Regulatory (8314)
Reports (16)
Research institute (1861)
Resumes & cover letters (50)
Rett syndrome (2)
RNA editing (3)
RSV (14)
Schizophrenia (20)
Series A (69)
Series B (38)
Service/supplier (2)
Sickle cell disease (57)
Southern California (1089)
Special edition (3)
Spinal muscular atrophy (109)
Sponsored (14)
Startups (1781)
State (1)
Stomach cancer (12)
Supply chain (16)
Tariffs (2)
The Weekly (26)
United States (10624)
Vaccines (373)
Venture capitalists (14)
Webinars (9)
Weight loss (50)
Women's health (13)
Worklife (3)
Date
Today (29)
Last 7 days (343)
Last 30 days (1341)
Last 365 days (17272)
2025 (4175)
2024 (18030)
2023 (20553)
2022 (25490)
2021 (27261)
2020 (24408)
2019 (20047)
2018 (14992)
2017 (15349)
2016 (14805)
2015 (17324)
2014 (12446)
2013 (11516)
2012 (11501)
2011 (11442)
2010 (10328)
Location
Africa (332)
Alabama (20)
Alaska (6)
Arizona (60)
Arkansas (7)
Asia (20220)
Australia (4359)
California (2884)
Canada (772)
China (303)
Colorado (108)
Connecticut (103)
Delaware (77)
Europe (47236)
Florida (326)
Georgia (69)
Idaho (26)
Illinois (207)
India (8)
Indiana (86)
Iowa (4)
Japan (82)
Kansas (23)
Kentucky (9)
Maine (49)
Maryland (391)
Massachusetts (2290)
Michigan (60)
Minnesota (125)
Mississippi (1)
Missouri (29)
Montana (10)
Nebraska (8)
Nevada (21)
New Hampshire (13)
New Jersey (827)
New Mexico (19)
New York (869)
North Carolina (454)
North Dakota (7)
Northern California (1305)
Ohio (110)
Oklahoma (9)
Oregon (12)
Pennsylvania (611)
Puerto Rico (3)
Rhode Island (13)
South America (407)
South Carolina (3)
Southern California (1089)
Tennessee (31)
Texas (469)
Utah (68)
Virginia (58)
Washington D.C. (18)
Washington State (361)
West Virginia (1)
Wisconsin (13)
305,576 Results for "universal cells".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Press Releases
LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer
February 25, 2025
·
4 min read
Press Releases
Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research
February 19, 2025
·
2 min read
Press Releases
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors
January 14, 2025
·
6 min read
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
March 17, 2025
·
2 min read
·
Tristan Manalac
Genetown
Cellular Origins and Cell and Gene Therapy Catapult Collaborate to Demonstrate Universal Automation of CGT Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies, and the Cell and Gene Therapy Catapult, an independent innovation and technology organisation specialising in the advancement of the cell and gene therapy industry, announced a collaboration to demonstrate universal automation of CGT manufacturing.
May 29, 2024
·
4 min read
Press Releases
Pluristyx Enables Safer, Universal Cell Therapy Solutions with Newly Issued U.S. Patent for iACT Stealth™ Technology
February 12, 2025
·
2 min read
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Press Releases
Cellares’ Cell Shuttle™ Receives FDA Advanced Manufacturing Technology (AMT) Designation for Automated Cell Therapy Manufacturing
April 1, 2025
·
3 min read
Pharm Country
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
Coeptis Therapeutics Holdings, Inc. announced today that the Company has been selected for an oral presentation of the abstract titled Developing A First-In-Class Universal Allogeneic Snap-Car NK Cell Therapy at the International Society for Cell & Gene Therapy 2024, being held May 28th to June 1st in Vancouver, Canada.
May 8, 2024
·
6 min read
1 of 30,558
Next
